Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07137286 · ClinicalTrials.gov registry record
A Study of Genetic Influence on LDL Hyper-responsiveness in Patients Following a Ketogenic Diet
A clinical trial of LDL Hyper-responsiveness, sponsored by Mayo Clinic.
- Recruiting
- Registry status
- 100
- Enrollment target
- 1
- Study location
NCT07137286: Recruiting study of LDL Hyper-responsiveness, sponsored by Mayo Clinic.
NCT07137286 is a study of LDL Hyper-responsiveness that is actively recruiting participants, run by Mayo Clinic. The registered enrollment target is 100 participants. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07137286, a study of LDL Hyper-responsiveness, is actively recruiting participants, sponsored by Mayo Clinic.
- RECRUITING
- Registry status
- 100 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to identify whether individuals following a ketogenic diet who experience extreme LDL-C elevation, termed "hyper-responders", have identifiable genetic variations in genes involved in cholesterol absorption.
Primary Outcome
Genetic Mutation will be defined as a mutation in ABCG5, ABCG8, APOB, APOE, CETP, CYP27A1, LDLR, LDLRAP1, LIPA, LPL, LRP6, and PCSK9 genes
Conditions Studied
Study Locations (1)
Minnesota
- Mayo Clinic - Rochester
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2025-09-11 |
| Est. Completion | 2027-08 |
What NCT07137286 shows while recruiting
NCT07137286 is an observational study that tracks outcomes without assigning an intervention. The registered 100 participants enrollment target is mid-sized for trials with a published cap.
The record links to 1 condition, with LDL Hyper-responsiveness appearing as the primary indexed condition, and to 0 interventions.
NCT07137286 reports a single indexed study location in Minnesota.
Frequently Asked Questions
What is clinical trial NCT07137286 about?
NCT07137286 is a clinical study titled "A Study of Genetic Influence on LDL Hyper-responsiveness in Patients Following a Ketogenic Diet". The purpose of this study is to identify whether individuals following a ketogenic diet who experience extreme LDL-C elevation, termed "hyper-responders", have identifiable genetic variations in genes involved in cholesterol absorption.
What is the current status of trial NCT07137286?
This trial is currently recruiting. The enrollment target is 100 participants. The study started on 2025-09-11. Estimated completion is 2027-08.
What conditions does trial NCT07137286 study?
This clinical trial studies the following conditions: LDL Hyper-responsiveness.
Who is sponsoring clinical trial NCT07137286?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07137286 being conducted?
This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01048281 · 100 participants
Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma
- NCT01161199 · 100 participants
The Use of Leukapheresis to Support HIV Pathogenesis Studies
- NCT01327690 · 100 participants · Early Phase 1
Mental Health in Veterans and Families After Group Therapies
- NCT01730781 · 100 participants
Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI